Kura Oncology grants inducement stock options for 68,750 shares at $10.78 each

Kura Oncology, Inc.

Kura Oncology, Inc.

KURA

0.00
  • Kura Oncology reported inducement grants of nonstatutory stock options covering 68,750 shares to five new employees under its 2023 Inducement Option Plan.
  • Options were priced at USD 10.78 per share, set at the July 1, 2026 closing price.
  • Awards vest over four years, with 25% vesting after one year; remaining shares vest monthly over the next 36 months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607030730PRIMZONEFULLFEED9756338) on July 03, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.